ONS/ONCC Chemotherapy Biotherapy Certification Exam (2023/ 2024 Update) Questions and Verified Answers|100% Correct- Grade A
ONS/ONCC Chemotherapy Biotherapy Certification Exam (2023/ 2024 Update) Questions and Verified Answers|100% Correct- Grade A Q: True or False: When administering an IV push medication the nurse should open the clamp of compatible intravenous solution until increased flow is seen to dilute the agent during administration Answer: True Q: During the 2 RN check, the correct patient and dose is to be verified at the -- Answer: bedside/chairside Q: Continuous infusion of vesicants must be through a -- Answer: Central Line Q: Family and -- of the patient need taught about excretion safety precautions Answer: friends Q: Excretion safety precautions last for -- to -- days Answer: 3, 7 Q: True or False: When evaluating a patient prior to chemotherapy, the nurse notes the patient recently had weight loss. The nurse recalculates the dose and discovers the change in the dose is greater than 5%. The next step for the nurse is to notify the attending physician that the patient will need re-consented because of the dose adjustment Answer: False Q: Alkylating agents are cell cycle specific. They work on -- and resting cells Answer: dividing Q: Alkylating agents are effective in slow growing tumors and large tumors that have few actively -- cells Answer: dividing Q: List three toxicities common in all alkylating agents: Answer: 1. Nausea 2. Vomiting 3. Myelosuppression 4. Infertility 5. Alopecia 6. Tumor Lysis Syndrome (TLS) Q: Which class of drugs can cross the blood brain barrier, increasing a patient's risk for CNS toxicities? Answer: Nitrosureas Q: -- is the solvent of carmustine (BCNU) Answer: Sterile Alcohol Q: The -- formula ia used to calculate Carboplatin dosage Answer: Calvert Q: True or False: Temozolamide (Temodar) effectively crosses the blood brain barrier Answer: True Q: Patients may feel intoxicated during the administration of -- Answer: Carmustine (BCNU) Q: Patients are prophylactically medicated with anticonvulsants before receiving -- and for 24 hours after the last dose to prevent seizures Answer: Busulfan Q: True or False: Oxaliplatin should only be mixed with D5W Answer: True Q: Which drug should ALWAYS be given with Mesna? Answer: Ifosfamide Q: Pulmonary fibrosis is a late complication of patients who receive -- Answer: Busulfan Q: The platinum alkylating agents include --, --, and -- Answer: Cispiatin, Carboplatin, Oxaliplatin Q: Cisplatin (Platinol) is a -- emetogenic drug
Written for
- Institution
- ONS/ONCC Chemotherapy
- Course
- ONS/ONCC Chemotherapy
Document information
- Uploaded on
- October 28, 2023
- Number of pages
- 50
- Written in
- 2023/2024
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
- onsoncc chemotherapy
-
cisplatin platinol is a emetogenic drug
-
onsoncc chemotherapy biotherapy certification exa
-
e or false when administering an iv push medicati
-
ons chemotherapy immunotherapy certi
Also available in package deal